Axsome Therapeutics, Inc. (AXSM)
AXSM price $156.60 +0.29 +0.19%
- Ticker
- AXSM
- Price
- $156.60
- Change
- +0.29 +0.19%
- Market cap
- $8.20B
- P/E
- -41.68
- Forward P/E
- 39.57
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 66
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is…